Modi, S., Soejima, M., & Levesque, M. C. (2013). The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses. Clinical & Experimental Immunology, 173(1), 8. https://doi.org/10.1111/cei.12114
Chicago Style (17th ed.) CitationModi, S., M. Soejima, and M. C. Levesque. "The Effect of Targeted Rheumatoid Arthritis Therapies on Anti-citrullinated Protein Autoantibody Levels and B Cell Responses." Clinical & Experimental Immunology 173, no. 1 (2013): 8. https://doi.org/10.1111/cei.12114.
MLA (9th ed.) CitationModi, S., et al. "The Effect of Targeted Rheumatoid Arthritis Therapies on Anti-citrullinated Protein Autoantibody Levels and B Cell Responses." Clinical & Experimental Immunology, vol. 173, no. 1, 2013, p. 8, https://doi.org/10.1111/cei.12114.